Dede Willams

Mylan Board Unanimously Rejects Teva’s Bid

Solvay Building Korean Plant for Tire-grade Silica

EU Authorizes 17 GMOs for Food and Feed

DuPont to Buy Microbials Specialist Taxon Biosciences

BASF in Chinese Automotive Refinish Coatings Deal

Total Spending €600 Million on Refinery Conversions

Mylan Said to Prepare Poison Pill Potion Against Teva

EU Commission Finalizes New GMO Import Rules

Daiichi Sankyo Unloads Entire Stake in Sun Pharma

US Chemical Activity Barometer Suggests 2015 Gains

US Shale Gas Advantage Will Hold, ACC Chief Says

Kuraray Expands into Bio-based Barrier Materials

Lenorplastics to Market Evonik PMMA Compounds

Teva Makes $40 Billion Cash-and-Stock Bid for Mylan

Sartorius Stedim Biotech Buys BioOutsource

Bayer CropScience to Invest at Evonik’s Alabama Site

SABIC in Shale Gas Deal With Unnamed US Supplier

Huntsman Increases Specialty Amine Capacity

AbbVie and Puerto Rico Announce $30 Million Expansion

BASF Chooses Freeport for World-Scale Methanol Complex

FDA Approves the First-Ever US Biosimilar

EPA Chief Warns States Over Emission Rules

Endo International Tries to Spoil Valeant’s Salix Deal

PlastiComp and Xenia Link up on Composites

Ineos Integrates its North American ABS Business

Evonik to Acquire Indian Specialty Catalyst Maker

Clariant Sells Energy Storage Business to Johnson Matthey

Bayer Has “Great Plans” for Life Sciences, CEO Says

Solvay and 3A Composites in Global Foams Alliance

Wacker “Examines Options” for Siltronic

Ineos Plans to Buy More UK Shale Gas Licences

Merck Serono and Illumina in Oncology Diagnostics Pact

Arkema to Expand PEKK Output in France and the US

Wacker Widens US Capacity for Dispersions

Merck & Co to Cut Jobs at Newly Acquired Cubist

789 more articles

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing